DK0613375T3 - Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf - Google Patents

Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf

Info

Publication number: DK0613375T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; lysine; glx; containing polypeptide; polypeptide preparations
Prior art date: 1991-10-28

Application number

DK92923065T

Other languages

English (en)

Inventor

Boris V Vaskovsky

Lawrence R Green

Vadim T Ivanov

Inessa I Mikhalyova

Alexander N Mikhaltsov

Vladimir K Khavinson

Vyacheslav G Morozov

Original Assignee

Melmotte Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-28

Filing date

1992-10-28

Publication date

2004-07-12

1992-10-28 Application filed by Melmotte Inc filed Critical Melmotte Inc

2004-07-12 Application granted granted Critical

2004-07-12 Publication of DK0613375T3 publication Critical patent/DK0613375T3/da

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
239000004472 Lysine Substances 0.000 title 1
229920001184 polypeptide Polymers 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
208000001388 Opportunistic Infections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DK92923065T 1991-10-28 1992-10-28 Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf DK0613375T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US78351791A	1991-10-28	1991-10-28

Publications (1)

Publication Number	Publication Date
DK0613375T3 true DK0613375T3 (da)	2004-07-12

Family

ID=25129521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92923065T DK0613375T3 (da)	1991-10-28	1992-10-28	Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf

Country Status (10)

Country	Link
EP (1)	EP0613375B1 (da)
JP (1)	JPH07503705A (da)
KR (1)	KR100266929B1 (da)
AT (1)	ATE260672T1 (da)
AU (1)	AU665789B2 (da)
CA (1)	CA2122024A1 (da)
DE (1)	DE69233315T2 (da)
DK (1)	DK0613375T3 (da)
ES (1)	ES2217255T3 (da)
WO (1)	WO1993008816A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5807830A (en) *	1987-12-30	1998-09-15	Cytoven J.V.	Method for treatment of purulent inflammatory diseases
US6066622A (en)	1991-10-28	2000-05-23	Cytran, Inc.	Immunomodulating peptides and methods of use
CA2127275A1 (en) *	1992-01-02	1993-07-08	Cytran, Ltd.	Pharmaceutical pentapeptide compositions and methods of use thereof
AU7392294A (en) *	1993-07-21	1995-02-20	Vladimir Khatskelevich Khavinson	Pharmaceutical with immunomodulating activity
US7868206B2 (en)	2005-12-27	2011-01-11	National University Corporation, Gunma University	Trihalomethionine derivative and pharmaceutical product containing the same
US20170260235A1 (en) *	2010-04-27	2017-09-14	Chanel Parfums Beaute	Polypeptide expressed in the stratum corneum and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE780993A (fr) *	1971-03-26	1972-09-21	Merck & Co Inc	Hemopeptides et leur procede de preparation
US4395404A (en) *	1982-05-14	1983-07-26	George Washington University	Synthetic thymosin β3 and β4 analogues
DE3421614A1 (de) *	1984-06-09	1985-12-12	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens

1992
- 1992-10-28 WO PCT/US1992/009252 patent/WO1993008816A1/en not_active Ceased
- 1992-10-28 CA CA002122024A patent/CA2122024A1/en not_active Abandoned
- 1992-10-28 DE DE69233315T patent/DE69233315T2/de not_active Expired - Fee Related
- 1992-10-28 AT AT92923065T patent/ATE260672T1/de not_active IP Right Cessation
- 1992-10-28 EP EP92923065A patent/EP0613375B1/en not_active Expired - Lifetime
- 1992-10-28 DK DK92923065T patent/DK0613375T3/da active
- 1992-10-28 AU AU29155/92A patent/AU665789B2/en not_active Ceased
- 1992-10-28 KR KR1019940701386A patent/KR100266929B1/ko not_active Expired - Fee Related
- 1992-10-28 JP JP5508573A patent/JPH07503705A/ja not_active Ceased
- 1992-10-28 ES ES92923065T patent/ES2217255T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2217255T3 (es)	2004-11-01
AU665789B2 (en)	1996-01-18
DE69233315T2 (de)	2005-03-31
EP0613375A4 (en)	1996-08-07
EP0613375A1 (en)	1994-09-07
ATE260672T1 (de)	2004-03-15
JPH07503705A (ja)	1995-04-20
AU2915592A (en)	1993-06-07
WO1993008816A1 (en)	1993-05-13
DE69233315D1 (de)	2004-04-08
EP0613375B1 (en)	2004-03-03
CA2122024A1 (en)	1993-05-13
HK1013622A1 (en)	1999-09-03
KR100266929B1 (ko)	2000-09-15

Similar Documents

Publication	Publication Date	Title
ATE188219T1 (de)	2000-01-15	Pharmazeutische dipeptid zusammensetzungen und verwendungsmethoden.
BG101118A (en)	1998-04-30	Therapeutical compounds
TR199801180T2 (xx)	1998-10-21	Aneljestik etkiye sahip yeni bile�ikler.
RU95107881A (ru)	1996-11-27	Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
GEP20012413B (en)	2001-04-25	Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
LV10186A (lv)	1994-10-20	Cistina atvasinajumu pielietojums arstniecibas lidzeklu ar imunomodulejosu darbibu pagatavosanai farmaceitiskas kompozicijas uz to bazes
NO981436D0 (no)	1998-03-30	Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav
RU92016463A (ru)	1995-09-10	Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
BR9814498A (pt)	2000-10-10	Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
DK31991D0 (da)	1991-02-25	Peptid og farmaceutisk praeparat indeholdende et saadant peptid
IT1247528B (it)	1994-12-17	Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono
BG60101B2 (bg)	1993-10-29	Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
ATE3416T1 (de)	1983-06-15	Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
EP0613375A4 (en)	1996-08-07	PHARMACEUTICAL LYSINE CONTAINING POLYPEPTIDE COMPOSITIONS AND METHOD FOR USE THEREOF.
DE3883055D1 (de)	1993-09-16	Enkastine: neue glycopeptide mit enkephalinase-hemmender wirkung, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutische praeparate.
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
BR0011880A (pt)	2002-03-19	Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica
RU94040865A (ru)	1996-08-10	Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
NO923198L (no)	1993-02-16	Terapeutiske midler
DK0621789T3 (da)	1999-10-25	Farmaceutiske pentapeptidpræparater og fremgangsmåder til anvendelse deraf
RU93052408A (ru)	1996-07-20	Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
RU94046312A (ru)	1996-10-20	Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
MX9303074A (es)	1994-01-31	Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
EP0257418A3 (en)	1989-12-20	Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations
HUT67787A (en)	1995-04-28	Antibiotic ge 1655 complex and its a,b, and c factors, agricultural and pharmaceutical preparations containing them and a process for their production